Bausch Health Companies (BHC) Payables (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Payables came in at $593.0 million in Q2 2026, down 5.42% year-over-year from $627.0 million in Q2 2025, and little changed quarter-over-quarter from $593.0 million in Q1 2026.
Analysis
Bausch Health Companies (BHC) Payables (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Payables across 18 years of filings, most recently posting $593.0 million for Q2 2026.
- In Q2 2026, Payables fell 5.42% year-over-year to $593.0 million; the TTM figure through Jun 2026 stood at $593.0 million (down 5.42% YoY), while the FY2025 annual figure was $600.0 million, up 1.87% from the prior year.
- Payables came in at $593.0 million for Q2 2026 at Bausch Health Companies, roughly flat from $593.0 million in the prior quarter.
- In the past five years, Payables ranged from a high of $719.0 million in Q4 2023 to a low of $471.0 million in Q1 2022.
- Average Payables over 5 years is $583.6 million, with a median of $591.0 million recorded in 2024.
- Year-over-year, Payables jumped 38.0% in 2023 and dropped 18.08% in 2024.
- Over 5 years, Payables stood at $521.0 million in 2022, then surged by 38.0% to $719.0 million in 2023, then decreased by 18.08% to $589.0 million in 2024, then advanced by 1.87% to $600.0 million in 2025, then declined by 1.17% to $593.0 million in 2026.
- Per Business Quant data, the three most recent Payables figures were $593.0 million in Q2 2026, $593.0 million in Q1 2026, and $600.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.33 Bn | 38.68 Bn | 2.15 Bn | 2.72 Bn |
| 2 | Viatris | 19.05 Bn | 18.16 Bn | 1.46 Bn | 1.73 Bn |
| 3 | Dr Reddys Laboratories | 9.76 Bn | 9.58 Bn | 396.53 Mn | 449.39 Mn |
| 4 | Amneal Pharmaceuticals | 5.38 Bn | 5.25 Bn | 334.51 Mn | 721.21 Mn |
| 5 | Bausch Health Companies | 2.27 Bn | 436.38 Mn | 2.10 Bn | 593.00 Mn |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn | 171.84 Mn |
| 7 | Ani Pharmaceuticals | 1.51 Bn | 1.15 Bn | 165.89 Mn | 73.83 Mn |
| 8 | Amphastar Pharmaceuticals | 1.03 Bn | 737.26 Mn | 93.47 Mn | 251.37 Mn |
| 9 | Fennec Pharmaceuticals | 393.12 Mn | 351.87 Mn | 17.15 Mn | 5.52 Mn |
| 10 | RedHill Biopharma | 171.02 Mn | 171.02 Mn | - | 731,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 593.00 Mn |
| Mar 31, 2026 | 593.00 Mn |
| Dec 31, 2025 | 600.00 Mn |
| Sep 30, 2025 | 616.00 Mn |
| Jun 30, 2025 | 627.00 Mn |
| Mar 31, 2025 | 620.00 Mn |
| Dec 31, 2024 | 589.00 Mn |
| Sep 30, 2024 | 667.00 Mn |
| Jun 30, 2024 | 579.00 Mn |
| Mar 31, 2024 | 642.00 Mn |
| Dec 31, 2023 | 719.00 Mn |
| Sep 30, 2023 | 569.00 Mn |
| Jun 30, 2023 | 515.00 Mn |
| Mar 31, 2023 | 561.00 Mn |
| Dec 31, 2022 | 521.00 Mn |
| Sep 30, 2022 | 486.00 Mn |
| Jun 30, 2022 | 536.00 Mn |
| Mar 31, 2022 | 471.00 Mn |
| Dec 31, 2021 | 407.00 Mn |
| Sep 30, 2021 | 455.00 Mn |